Login
 
 
 
Forgotten Password?
 
The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Email Alert
Email Alert
Company profiles
Company profiles
Company Spotlight
Company Spotlight
Add to Portfolio or Watchlist
Add to Portfolio or Watchlist

IVO  IMPERIAL INNOVATIONS GROUP PLC  ORD 3 1/33P
IMPERIAL INNOV  Currency GBX 
Company
Market
Market




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 08-May-2013 IVO Cell Medica treats first patient in new trial RNS +1.09% Up
07:00 29-Apr-2013 IVO Investment team appointment RNS -0.04% Down
09:26 17-Apr-2013 IVO Board change RNS 0.00% 
07:00 22-Mar-2013 IVO Half year results RNS -4.59% Down
09:22 01-Mar-2013 IVO Notice of Results RNS +1.06% Up
08:38 01-Mar-2013 IVO Notification of major interest in shares RNS +1.06% Up
07:00 25-Feb-2013 IVO Circassia's cat allergy treatment RNS +1.18% Up
07:00 22-Feb-2013 IVO Nexeon partnership with Wacker RNS +0.53% Up
07:00 14-Feb-2013 IVO Investment in new technology company RNS -8.70% Down
07:00 23-Jan-2013 IVO £1.5m investment in new software portfolio company RNS +1.03% Up
15:45 21-Jan-2013 IVO Listing of shares RNS +0.25% Up
15:02 12-Dec-2012 IVO Result of AGM RNS +0.87% Up
07:00 16-Nov-2012 IVO Veryan CE Mark approval for BioMimics 3D Stent RNS +1.78% Up
07:00 05-Nov-2012 IVO Portfolio companies receive government funding RNS -0.13% Down
10:00 19-Oct-2012 IVO Grant of share options RNS -1.73% Down
07:00 05-Oct-2012 IVO Full year results RNS +0.42% Up
07:00 04-Oct-2012 IVO Circassia initiates phase III trial RNS -0.13% Down
07:00 26-Sep-2012 IVO PsiOxus commences clinical trial RNS +0.22% Up
12:39 20-Sep-2012 IVO Notice of Results RNS -1.27% Down
15:25 13-Sep-2012 IVO Circassia appoints Dr Brett Haumann as CMO RNS -0.52% Down

 Page 1 of 2

| 1 | 2 | Next


IMPERIAL INNOV - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds